Overview
- Researchers at the University of Zurich ran a controlled lab study in which 20 healthy young men completed three sleep conditions to search for molecular signs of sleep loss.
- The team analyzed oral fluid with high-resolution mass spectrometry and machine-learning models and identified a set of 10 salivary biomarkers that distinguish acute sleep deprivation from normal sleep.
- The study reports that acute sleep loss alters roughly 10% of detectable biomolecules in saliva and that a single sample can show the metabolic fingerprint of waking without sleep.
- Authors emphasize limits: the result comes from a small, demographically narrow sample in controlled conditions and the biomarker set must be validated against shift work, alcohol, medications and broader populations.
- If field validation succeeds, the finding could enable objective on-site fatigue tests for road and workplace safety, but practical use will require converting lab mass-spectrometry assays into a simple rapid test and regulatory and ethical review.